Jpmorgan Chase & CO Tela Bio, Inc. Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Tela Bio, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 133,666 shares of TELA stock, worth $323,471. This represents 0.0% of its overall portfolio holdings.
Number of Shares
133,666
Previous 339
39329.5%
Holding current value
$323,471
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding TELA
# of Institutions
52Shares Held
27.4MCall Options Held
754KPut Options Held
300-
Essex Woodlands Management, Inc. The Woodlands, TX4.11MShares$9.95 Million2.87% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.68MShares$8.9 Million0.56% of portfolio
-
Silverarc Capital Management, LLC3.07MShares$7.42 Million2.23% of portfolio
-
Aigh Capital Management LLC Baltimore, MD2.66MShares$6.44 Million3.26% of portfolio
-
Stonepine Capital Management, LLC Bend, OR2.35MShares$5.69 Million5.74% of portfolio
About TELA Bio, Inc.
- Ticker TELA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 19,157,600
- Market Cap $46.4M
- Description
- TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...